Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer
European Journal of Surgical Oncology · 2023
DOI: 10.1016/j.ejso.2023.06.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023. Verfasst von Laura E Gould und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK; St Mark's Academic Institute, St Mark'…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Pelvic Exenteration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Chief Scientist Office.
Abstract (Originalsprache)
INTRODUCTION: Pathological factors that influence and predict survival following pelvic exenteration (PE) for locally advanced (LARC) or locally recurrent rectal cancer (LRRC), especially LRRC, remain poorly understood. A clear resection margin has previously been demonstrated to be of most significance. MATERIALS AND METHODS: A retrospective cohort study was performed for all patients undergoing a curative PE for LARC or LRRC between 2008 and 2021 at a tertiary referral UK specialist colorectal hospital. Cox regression analysis was planned to identify pathological factors associated with overall (OS), disease free (DFS) and local recurrence free survival (LRFS). RESULTS: 388 patients were included in the analysis with 256 resections for LARC and 132 for LRRC. 62.4% of patients were male with a median age of 59 years (IQR 49-67). 247 (64%) partial pelvic exenterations and 141 (36%) total pelvic exenterations performed. Overall R0 rate 86.6%. Poorly differentiated tumours and a positive resection margin independently influenced OS, DFS and LRFS on multivariate analysis in LARC. On multivariate analysis venous invasion negatively influenced DFS and poorly differentiated lesions negatively influenced LRFS in LRRC. CONCLUSIONS: A positive resection margin and poorly differentiated tumours are significant negative prognostic markers for survival and recurrence in LARC. The results of this study support the need to look for alternative prognostic markers beyond that in the existing standard reporting dataset for rectal cancers. With increasing R0 rates, novel prognostic pathological markers are required to help guide treatment and surveillance for patients with LRRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK; St Mark's Academic Institute, St Mark's- The National Bowel Hospital, Harrow, UK. Electronic address: Laura.…
- St Mark's Academic Institute, St Mark's- The National Bowel Hospital, Harrow, UK.
- St Mark's Academic Institute, St Mark's- The National Bowel Hospital, Harrow, UK; Complex Cancer Clinic, St Mark's- The National Bowel Hospital, Harrow, UK.
- School of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK; Department of Surgery, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
Förderung
- Chief Scientist Office
Zitieren
APA
Gould, L. E., Pring, E. T., Moorghen, M., Burns, E. M., Antoniou, A., Steele, C. W., Roxburgh, C. S., & Jenkins, J. T. (2023). Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2023.06.023
Vancouver
Gould LE, Pring ET, Moorghen M, Burns EM, Antoniou A, Steele CW, et al. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer. European Journal of Surgical Oncology. 2023. doi:10.1016/j.ejso.2023.06.023
BibTeX
@article{Gould2023,
author = {Gould, Laura E and Pring, Edward T and Moorghen, Morgan and Burns, Elaine M and Antoniou, Anthony and Steele, Colin W and Roxburgh, Campbell Sd and Jenkins, John T},
title = {Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer},
journal = {European Journal of Surgical Oncology},
year = {2023},
doi = {10.1016/j.ejso.2023.06.023}
}
EUVIMED